{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:40:33Z","timestamp":1793745633351,"version":"4.6.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.biomaterials.2026.124441","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:42:13Z","timestamp":1783600933000},"page":"124441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synergistic immunotherapy of NSCLC enabled by a biomimetic nanodelivery system for autophagy-mediated MDSC reprogramming and metabolic modulation"],"prefix":"10.1016","volume":"336","author":[{"given":"Ziqi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4203-5045","authenticated-orcid":false,"given":"Zuping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124441_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/1759-7714.13246","article-title":"Oncogene addiction and tumor mutational burden in non\u2010small\u2010cell lung cancer: clinical significance and limitations","volume":"11","author":"Smolle","year":"2019","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124441_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/LCTT.S511767","article-title":"Emerging targets in non-small cell lung cancer","volume":"16","author":"Wang","year":"2025","journal-title":"LCTT"},{"key":"10.1016\/j.biomaterials.2026.124441_bib3","first-page":"598","article-title":"Managing resistance to immune checkpoint inhibitors in lung cancer: treatment and novel strategies","volume":"40","author":"Passaro","year":"2022","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.biomaterials.2026.124441_bib4","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.3390\/ijms21176176","article-title":"Resisting resistance to immune checkpoint therapy: a systematic review","volume":"21","author":"Haibe","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.biomaterials.2026.124441_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/08830185.2024.2333275","article-title":"Boosting immune responses in lung tumor immune microenvironment: a comprehensive review of strategies and adjuvants","volume":"43","author":"Gao","year":"2024","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1116016","article-title":"Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment","volume":"13","author":"Cao","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217272","article-title":"Cellular dynamics of tumor microenvironment driving immunotherapy resistance in non-small-cell lung carcinoma","volume":"604","author":"Huang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2026.124441_bib8","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1002\/jcp.26075","article-title":"Myeloid\u2010derived suppressor cells: important contributors to tumor progression and metastasis","volume":"233","author":"Safarzadeh","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124441_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124441_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000168","article-title":"Myeloid\u2010derived suppressor cells in hematologic diseases: promising biomarkers and treatment targets","volume":"3","author":"Bizymi","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.biomaterials.2026.124441_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/icb.2013.29","article-title":"Myeloid\u2010derived suppressor cells in cancer: recent progress and prospects","volume":"91","author":"Khaled","year":"2013","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib13","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.3390\/ijms21103599","article-title":"Understanding the differentiation, expansion, recruitment and suppressive activities of Myeloid-derived suppressor cells in cancers","volume":"21","author":"Lim","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.biomaterials.2026.124441_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/cancers13020210","article-title":"The functional crosstalk between Myeloid-derived suppressor cells and regulatory T cells within the immunosuppressive tumor microenvironment","volume":"13","author":"Haist","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2026.124441_bib15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/mp1004228","article-title":"The suppressive tumor microenvironment: a challenge in cancer immunotherapy","volume":"8","author":"Vasievich","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biomaterials.2026.124441_bib16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.18632\/oncotarget.28303","article-title":"Myeloid-derived suppressor cells: cancer, autoimmune diseases, and more","volume":"13","author":"Shibata","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2026.124441_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11515-015-1354-2","article-title":"Emerging roles of autophagy in metabolism and metabolic disorders","volume":"10","author":"Rocchi","year":"2015","journal-title":"Front. Biol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib18","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3390\/cells10102752","article-title":"Autophagy and the lysosomal system in cancer","volume":"10","author":"Kumar","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2026.124441_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/MOG.0b013e32833104f1","article-title":"Autophagy, immunity and human disease","volume":"25","author":"Heath","year":"2009","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib20","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/cncr.31335","article-title":"Targeting autophagy in cancer","volume":"124","author":"Onorati","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.biomaterials.2026.124441_bib21","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/jcb.27646","article-title":"Macrophage polarity in cancer: a review","volume":"120","author":"Najafi","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biomaterials.2026.124441_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.311","article-title":"Modulation of the immunity and inflammation by autophagy","volume":"4","author":"Gan","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.biomaterials.2026.124441_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154612","article-title":"Natural products targeting macrophages in tumor microenvironment are a source of potential antitumor agents","volume":"109","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biomaterials.2026.124441_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib25","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/term.3090","article-title":"Saikosaponin D: a potential therapeutic drug for osteoarthritis","volume":"14","author":"Jiang","year":"2020","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.biomaterials.2026.124441_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10286020.2018.1465937","article-title":"Saikosaponins: a review of pharmacological effects","volume":"20","author":"Li","year":"2018","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.biomaterials.2026.124441_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jcb.22126","article-title":"Mechanistic study of saikosaponin\u2010d (Ssd) on suppression of murine T lymphocyte activation","volume":"107","author":"Wong","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biomaterials.2026.124441_bib28","first-page":"1","article-title":"Saikosaponin-d attenuates Hashimoto's thyroiditis by regulating macrophage polarization","volume":"2022","author":"Du","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.biomaterials.2026.124441_bib29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.7150\/ijms.53024","article-title":"Saikosaponin-d increases radiation-induced apoptosis of hepatoma cells by promoting autophagy via inhibiting mTOR phosphorylation","volume":"18","author":"Wang","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.biomaterials.2026.124441_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11010-018-3358-0","article-title":"Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKK\u03b2\u2013AMPK\u2013mTOR pathway in ADPKD cells","volume":"449","author":"Shi","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biomaterials.2026.124441_bib31","first-page":"3697","article-title":"Saikosaponins targeting programmed cell death as anticancer agents: mechanisms and future perspectives","volume":"18","author":"Xiao","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.biomaterials.2026.124441_bib32","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1016\/j.apsb.2023.08.008","article-title":"Targeting autophagy and beyond: deconvoluting the complexity of Beclin-1 from biological function to cancer therapy","volume":"13","author":"Ye","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2026.124441_bib33","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1080\/13880209.2021.1992448","article-title":"Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics","volume":"59","author":"Zhou","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib34","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/jpp\/rgad052","article-title":"Pharmacological properties and derivatives of Saikosaponins\u2014a review of recent studies","volume":"75","author":"Zhu","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/03602532.2018.1430823","article-title":"Difference and alteration in pharmacokinetic and metabolic characteristics of low-solubility natural medicines","volume":"50","author":"Yan","year":"2018","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.biomaterials.2026.124441_bib36","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/pharmaceutics14051113","article-title":"Functionalization of nanoparticulate drug delivery systems and its influence in cancer therapy","volume":"14","author":"Seidu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2026.124441_bib37","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/17460441.2020.1750591","article-title":"Nanonization techniques to overcome poor water-solubility with drugs","volume":"15","author":"Da Silva","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.biomaterials.2026.124441_bib38","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2217\/nnm.13.177","article-title":"Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging","volume":"8","author":"Shi","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2026.124441_bib39","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/adma.201104763","article-title":"Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery","volume":"24","author":"Tang","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124441_bib40","first-page":"5745","article-title":"Multifunctional mesoporous silica nanoparticles for cancer therapy and imaging","volume":"26","author":"Dilnawaz","year":"2019","journal-title":"Comput. Mater. Contin."},{"key":"10.1016\/j.biomaterials.2026.124441_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2019.02.031","article-title":"Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer","volume":"89","author":"Li","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2026.124441_bib42","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.2147\/IJN.S202210","article-title":"Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery","volume":"14","author":"Naz","year":"2019","journal-title":"IJN"},{"key":"10.1016\/j.biomaterials.2026.124441_bib43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1667\/RR2565.1","article-title":"A novel bioluminescence orthotopic mouse model for advanced lung cancer","volume":"176","author":"Li","year":"2011","journal-title":"Radiat. Res."},{"key":"10.1016\/j.biomaterials.2026.124441_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1427s62","article-title":"Utility and applications of orthotopic models of human non\u2010small cell lung cancer (NSCLC) for the evaluation of novel and emerging cancer therapeutics","volume":"62","author":"Justilien","year":"2013","journal-title":"CP Pharmacology"},{"key":"10.1016\/j.biomaterials.2026.124441_bib45","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41401-021-00776-4","article-title":"Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy","volume":"43","author":"Li","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biomaterials.2026.124441_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216208","article-title":"Myeloid-derived suppressor cells deficient in cholesterol biosynthesis promote tumor immune evasion","volume":"564","author":"Chen","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2026.124441_bib47","article-title":"Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124441_bib48","article-title":"Nanomedicine targeting myeloid\u2010derived suppressor cells enhances anti\u2010tumor immunity","volume":"13","author":"Yang","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2026.124441_bib49","article-title":"Re-polarizing myeloid-derived suppressor cells (MDSCs) with cationic polymers for cancer immunotherapy","volume":"6","author":"He","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2026.124441_bib50","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/1535-7163.MCT-17-0981","article-title":"Scavenger receptor type B1 and lipoprotein nanoparticle inhibit Myeloid-derived suppressor cells","volume":"17","author":"Plebanek","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.biomaterials.2026.124441_bib51","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.1007\/s00210-024-03764-7","article-title":"Nanoparticle innovations in targeted cancer therapy: advancements in antibody\u2013drug conjugates","volume":"398","author":"Abdelhamid","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.biomaterials.2026.124441_bib52","doi-asserted-by":"crossref","first-page":"11647","DOI":"10.1039\/D0NR02387F","article-title":"Refined construction of antibody-targeted nanoparticles leads to superior antigen binding and enhanced delivery of an entrapped payload to pancreatic cancer cells","volume":"12","author":"Greene","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2026.124441_bib53","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s11517-017-1759-y","article-title":"Development and preclinical trials of a wire-driven end effector device for frozen shoulder treatment","volume":"56","author":"Park","year":"2017","journal-title":"Med. Biol. Eng. Comput."},{"key":"10.1016\/j.biomaterials.2026.124441_bib54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-med-051013-052304","article-title":"Regulation of tumor metastasis by myeloid-derived suppressor cells","volume":"66","author":"Condamine","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.biomaterials.2026.124441_bib55","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/pbc.24251","article-title":"Clinical features and outcomes in patients with secondary Ewing sarcoma","volume":"60","author":"Applebaum","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.biomaterials.2026.124441_bib56","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib57","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2026.124441_bib58","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1038\/cddis.2013.217","article-title":"Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells","volume":"4","author":"Wong","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biomaterials.2026.124441_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02499","article-title":"Reactive oxygen species as regulators of MDSC-mediated immune suppression","volume":"9","author":"Ohl","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib60","article-title":"Modified method for differentiation of myeloid-derived suppressor cells in vitro enhances immunosuppressive ability via glutathione metabolism","volume":"33","author":"Zhou","year":"2023","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.biomaterials.2026.124441_bib61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/cdd.2014.145","article-title":"\u03b2-Catenin and NF-\u03baB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer","volume":"22","author":"Jia","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biomaterials.2026.124441_bib62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tibs.2010.07.007","article-title":"Regulation of autophagy by ROS: physiology and pathology","volume":"36","author":"Scherz-Shouval","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biomaterials.2026.124441_bib63","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1471-4906(03)00132-7","article-title":"L-arginine metabolism in myeloid cells controls T-lymphocyte functions","volume":"24","author":"Bronte","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib65","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3109\/08820139.2012.680634","article-title":"Metabolism of L-Arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives","volume":"41","author":"Raber","year":"2012","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.biomaterials.2026.124441_bib66","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib67","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","article-title":"Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function","volume":"32","author":"Condamine","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2026.124441_bib68","first-page":"629","article-title":"The complex interplay between autophagy and NF-\u03baB signaling pathways in cancer cells","volume":"1","author":"Trocoli","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124441_bib69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/smll.201001459","article-title":"In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation","volume":"7","author":"He","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2026.124441_bib70","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2012.05.046","article-title":"In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics","volume":"163","author":"Yu","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124441_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115049","article-title":"Biosafety of mesoporous silica nanoparticles; towards clinical translation","volume":"201","author":"L\u00e9rida-Viso","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124441_bib72","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.biomaterials.2010.10.035","article-title":"Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice","volume":"32","author":"Liu","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124441_bib73","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jconrel.2020.05.027","article-title":"One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility","volume":"324","author":"Mohammadpour","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124441_bib74","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat. Nanotechnol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:48:55Z","timestamp":1787777335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226004655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":74,"alternative-id":["S0142961226004655"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124441","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic immunotherapy of NSCLC enabled by a biomimetic nanodelivery system for autophagy-mediated MDSC reprogramming and metabolic modulation","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124441"}}